Compare NKX & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NKX | MLAB |
|---|---|---|
| Founded | 2002 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Industrial Machinery/Components |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 640.3M | 719.9M |
| IPO Year | N/A | 1995 |
| Metric | NKX | MLAB |
|---|---|---|
| Price | $11.70 | $121.64 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $94.00 |
| AVG Volume (30 Days) | ★ 146.4K | 134.5K |
| Earning Date | 01-01-0001 | 05-27-2026 |
| Dividend Yield | ★ 4.37% | 0.67% |
| EPS Growth | N/A | ★ 436.11 |
| EPS | N/A | ★ 0.49 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $6.07 |
| Revenue Next Year | N/A | $5.41 |
| P/E Ratio | ★ N/A | $252.88 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.68 | $61.42 |
| 52 Week High | $13.20 | $132.70 |
| Indicator | NKX | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 25.22 | 53.02 |
| Support Level | N/A | $94.20 |
| Resistance Level | $12.49 | N/A |
| Average True Range (ATR) | 0.09 | 4.33 |
| MACD | -0.04 | -1.11 |
| Stochastic Oscillator | 12.28 | 13.75 |
Nuveen California AMT-Free Quality Municipal Income Fund is a closed-end fixed income mutual fund. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Arizona individual income taxes and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued. It invests across sectors such as healthcare, utilities, transportation, and housing.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.